




- Alonso-Monge R, Gresnigt MS, Román E, Hube B, Pla J. Candida albicans colonization of the gastrointestinal tract: A double-edged sword. PLoS Pathog. 2021 Jul 22;17(7):e1009710. doi: 10.1371/journal.ppat.1009710. PMID: 34293071; PMCID: PMC8297749. ↩︎
- Soliman et al. (2025). Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives. Nutrients, 17(8), 1365. https://doi.org/10.3390/nu17081365 ↩︎
- Reizdarm Podcast (2023): Candida im Darm – Symptome, Test- und Behandlungsmöglichkeiten mit Dr. Thomas Bacharach ↩︎
- Athenslab.gr (2025):https://athenslab.gr/en/blog/infections/candidiasis-symptoms-causes-testing-and-treatment ↩︎
- Derek & Savage (2025): Candida albicans gastrointestinal colonization resistance: a host-microbiome blancing act. 93(9):e00610-24. doi: 10.1128/iai.00610-24t. ↩︎
- Henrici, A., Gastmeier, P., & Meyer, E. (2021). Risk Factors for Invasive Candida Infection in Critically Ill Patients: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. ↩︎
- Ventin-Holmberg et al. (2022). The effect of antibiotics on the infant gut fungal microbiota. Journal of Fungi, 8(4), 328. https://pubmed.ncbi.nlm.nih.gov/35448562/ ↩︎
- Erdogan, A. & RAo, S. S. C. (2014): Small intestinal fungal overgrowth (SIIFO). Current Gastroenterology Reports,16, 377. doi:10.1007/s11894-014-0377-5 ↩︎
- Soliman, N. & Kruithoff, C. (2025): Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives. Nutritients. 2025 April 17; 17(8): 1365. doi: 10.3390/nu17081365 ↩︎
- Rao, S.S.C.; Tan, G.; Abdulla, H.; Yu, S.; Larion, S.; Leelasinjaroen, P. Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)? Clin. Transl. Gastroenterol. 2018, 9, 146. ↩︎
- Erdogen, A. & RAo, S. S. C. (2014): Small intestinal fungal overgrowth (SIIFO). Current Gastroenterology Reports,16, 377. doi:10.1007/s11894-014-0377-5 ↩︎
- Soliman, N.& Kruithoff, C. (2025): Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives. Nutritients. 2025 April 17; 17(8): 1365. doi: 10.3390/nu17081365 ↩︎
- Truss CO (1981) The role of Candida albicans in human illness.J Orthomol Psychiatry 10:228-238 ↩︎
- Truss CO (1983) The Missing Diagnosis.The Missing Diagnosis, Inc., Birmingham, Alabama ↩︎
- Reizdarm Podcast (2023): Candida im Darm – Symptome, Test- und Behandlungsmöglichkeiten mit Dr. Thomas Bacharach ↩︎
- Soliman, N. et al. (2025): Smal Intestianl Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives ↩︎
- Singh R. & Mullin G.E. A (2017): Wasting Syndrome and Malnutrition Caused by Small Intestine Fungal Overgrowth: Case Report and Review of the Literature. Integr. Med. A Clin. J. 2017;16:48–51. ↩︎
- Soliman, N. et al. (2025): Smal Intestianl Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives ↩︎
- Jawhara, S. (2023): How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation. Microorganisms, 10, 1014. doi:10.3390/microorganisms10051014 ↩︎
- Jawhara, S. (2023): Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection. Microorganisms, 11(6), 1556. doi:10.3390/microorganisms11061556 ↩︎
- Oyom, P et al. (2020): Prevalence and antifungal susceptibility of gastrointestinal candidiasis among diabetic patients. African Journal of Laboratory Medicine. ↩︎
- Jacobs C. et al. (2013): Dysmotilität und Protonenpumpenhemmer sind unabhängige Risikofaktoren für kleine Darmbakterien- und/oder Pilzüberwucherungen. Aliment. Pharmakol. Dort. ;37:1103–1111. doi: 10.1111/apt.12304. ↩︎
- Universitätsklinikum Giessen. https://www.ukgm.de/ugm_2/deu/ugi_mik/6860.html?utm_source=chatgpt.com ↩︎
- Banaszak M. et al. (2023): Association between Gut Dysbiosis and the Occurrence of SIBO, IMO and SIFO. Microorganisms ↩︎